土耳其多发性硬化症的流行和发病率:一项全国性的流行病学研究
Bilgin Öztürk1, Esra Taşkıran2, Serkan Demir3
1Department of Neurology, University of Health Sciences Gülhane Training and Research Hospital, Ankara, Turkey.
Multiple sclerosis (Houndmills, Basingstoke, England)
|April 15, 2024
概括
这项研究使用国家健康记录确定了土耳其多发性硬化症 (MS) 的流行病学概况. 多发性硬化症的患病率为每10万人中96.4例,女性与男性的比例为2.1:1.
科学领域:
- 神经学 神经学
- 流行病学 流行病学
- 公共卫生 公共卫生
背景情况:
- 多发性硬化症 (MS) 在全球范围内表现出不同的流行率和流行病学模式.
- 了解区域性MS流行病学对于公共卫生规划和资源分配至关重要.
研究的目的:
- 建立土耳其多发性硬化症 (MS) 的综合流行病学概况.
- 利用官方健康记录进行准确的流行率和发病率估计.
主要方法:
- 来自卫生部的整个土耳其人口数据的分析.
- 包括ICD代码G35的患者,重点是被诊断至少三次的患者.
- 计算流行率,发病率和人口统计数据 (年龄,性别,地点,诊断年份).
主要成果:
- 确定了201,061名ICD代码G35的患者,其中82,225人符合重复诊断的标准.
- 计算的多发性硬化症患病率为每10万人口中的96.4.
- 确定2022年每10万人发生率为6.2,女性与男性的比例为2.1:1,平均年龄为43.1岁,诊断时的平均年龄为34.0岁.
结论:
- 该研究提供了土耳其多发性硬化症 (MS) 的关键流行病学数据,基于大量的全人口数据集.
- 这些发现突显了土耳其境内的疾病负担和人口分布,为未来的卫生战略提供了信息.
- 这项研究强调了官方卫生数据库在慢性疾病流行病学监测方面的价值.
更多相关视频
09:46Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
Published on: September 21, 2021
4.7K
05:44Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
Published on: October 13, 2023
1.4K
相关概念视频
01:08Prevalence and Incidence
2.3K
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
2.3K
01:19Multiple Sclerosis l: Introduction
32
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
32